Call Us for More Information
800.615.2270

Completed Clinical Trials

Bevacizumab (Avastin) and Erlotinib (Tarceva) in Previously Treated Mesothelioma

  • Conditions: Mesothelioma
  • Status: Completed
  • Last Updated: December 23, 2011

An Open-label, Phase II Trial of ZD1839 (IRESSA) in Patients With Malignant Mesothelioma

  • Conditions: Mesothelioma
  • Status: Completed
  • Last Updated: May 10, 2011

SU5416 in Treating Patients With Malignant Mesothelioma

  • Conditions: Malignant Mesothelioma
  • Status: Completed
  • Last Updated: February 26, 2009

Gefitinib in Treating Patients With Malignant Mesothelioma

  • Conditions: Malignant Mesothelioma
  • Status: Completed
  • Last Updated: December 26, 2009

Safety Confirmation Study of Pemetrexed Plus Cisplatin in Patients With Malignant Pleural Mesothelioma

  • Conditions: Malignant Pleural Mesothelioma
  • Status: Completed
  • Last Updated: April 10, 2007

Surgery and Photodynamic Therapy in Treating Patients With Malignant Mesothelioma

  • Conditions: Malignant Mesothelioma
  • Status: Completed
  • Last Updated: February 25, 2011

Pemetrexed Plus Gemcitabine or Carboplatin for Patients With Advanced Malignant Pleural Mesothelioma

  • Conditions: Mesothelioma
  • Status: Completed
  • Last Updated: March 8, 2012

Gemcitabine and Epirubicin in Treating Patients With Malignant Mesothelioma

  • Conditions: Malignant Mesothelioma
  • Status: Completed
  • Last Updated: July 23, 2008

Capecitabine in Treating Patients With Malignant Mesothelioma

  • Conditions: Malignant Mesothelioma
  • Status: Completed
  • Last Updated: April 1, 2011

PTK787/ZK 222584 in Treating Patients With Unresectable Malignant Mesothelioma

  • Conditions: Malignant Mesothelioma
  • Status: Completed
  • Last Updated: March 17, 2011

Ecteinascidin 743 in Treating Patients With Malignant Mesothelioma

  • Conditions: Malignant Mesothelioma
  • Status: Completed
  • Last Updated: July 23, 2008

Dendritic Cell-based Immunotherapy in Mesothelioma

  • Conditions: Malignant Pleural Mesothelioma
  • Status: Completed
  • Last Updated: November 15, 2010

Erlotinib in Treating Patients With Malignant Mesothelioma of the Lung

  • Conditions: Malignant Mesothelioma
  • Status: Completed
  • Last Updated: January 28, 2009

AZD2171 in Treating Patients With Malignant Mesothelioma That Cannot Be Removed By Surgery

  • Conditions: Malignant Mesothelioma
  • Status: Completed
  • Last Updated: March 7, 2012

Sunitinib in Treating Patients With Advanced Malignant Pleural Mesothelioma

  • Conditions: Malignant Mesothelioma
  • Status: Completed
  • Last Updated: January 9, 2012

Combination Chemotherapy Before Surgery in Treating Patients With Mesothelioma of the Lung

  • Conditions: Malignant Mesothelioma
  • Status: Completed
  • Last Updated: April 12, 2012

Gemcitabine in Long Infusion and Cisplatin for Malignant Pleural Mesothelioma Treatment

  • Conditions: Malignant Pleural Mesothelioma
  • Status: Completed
  • Last Updated: November 17, 2010

Cisplatin, Pemetrexed and Bevacizumab for Untreated Malignant Mesothelioma

  • Conditions: Mesothelioma
  • Status: Completed
  • Last Updated: August 16, 2010

Study of Carboplatin and Vinorelbine in Malignant Pleural Mesothelioma

  • Conditions: Malignant Pleural Mesothelioma
  • Status: Completed
  • Last Updated: September 17, 2009

Cisplatin, Interferon Alfa, Surgery, and Radiation Therapy in Treating Patients With Malignant Pleural Mesothelioma

  • Conditions: Malignant Mesothelioma
  • Status: Completed
  • Last Updated: February 11, 2010

Liposomal-Cisplatin Analogue (L-NDDP) in Treating Patients With Malignant Pleural Mesothelioma

  • Conditions: Malignant Mesothelioma
  • Status: Completed
  • Last Updated: March 25, 2011

Combination Chemotherapy With or Without Bevacizumab in Treating Patients With Malignant Mesothelioma

  • Conditions: Malignant Mesothelioma
  • Status: Completed
  • Last Updated: September 17, 2010

Pemetrexed Plus Cisplatin Neoadjuvant Therapy Followed By Surgery and Radiation in Mesothelioma

  • Conditions: Mesothelioma
  • Status: Completed
  • Last Updated: May 5, 2011

Vaccine Therapy and GM-CSF in Treating Patients With Acute Myeloid Leukemia, Myelodysplastic Syndromes, Non-Small Cell Lung Cancer, or Mesothelioma

  • Conditions: Leukemia, Lung Cancer, Malignant Mesothelioma, Myelodysplastic Syndromes, Primary Peritoneal Cavity Cancer
  • Status: Completed
  • Last Updated: April 23, 2011

Decitabine in Treating Patients With Unresectable Lung or Esophageal Cancer or Malignant Mesothelioma of the Pleura

  • Conditions: Esophageal Cancer, Lung Cancer, Malignant Mesothelioma, Metastatic Cancer
  • Status: Completed
  • Last Updated: December 13, 2008

A Study of MORAb-009 in Subjects With Pancreatic Cancer, Mesothelioma, or Certain Types of Ovarian or Lung Cancer

  • Conditions: Pancreatic Cancer, Mesothelioma, Ovarian Cancer, Non-Small Cell Lung Cancer
  • Status: Completed
  • Last Updated: December 2, 2008

Study of Pemetrexed in Mesothelioma and Lung Cancer Patients With Fluid Around the Lungs or Abdomen

  • Conditions: Non-small Cell Lung Cancer, Mesothelioma, Lung Neoplasms
  • Status: Completed
  • Last Updated: June 10, 2010

Study of Pemetrexed Plus Cisplatin in Patients With Malignant Pleural Mesothelioma

  • Conditions: Malignant Pleural Mesotherioma
  • Status: Completed
  • Last Updated: November 5, 2007

Treatment of Peritoneal Cancer With Surgery, Perfused Heated Cisplatin and Chemotherapy

  • Conditions: Abdominal Neoplasm, Colonic Neoplasm, Mesothelioma, Peritoneal Neoplasm
  • Status: Completed
  • Last Updated: November 29, 2011

Alanosine in Treating Patients With Cancer

  • Conditions: Lung Cancer, Malignant Mesothelioma, Pancreatic Cancer, Sarcoma
  • Status: Completed
  • Last Updated: December 11, 2009

Phase I Study of Gene Induction Mediated by Sequential Decitabine/Depsipeptide Infusion With or Without Concurrent Celecoxib in Subjects With Pulmonary and Pleural Malignancies

  • Conditions: Small Cell Carcinoma, Mesothelioma, Non-Small-Cell Lung Carcinoma
  • Status: Completed
  • Last Updated: March 14, 2012

EF5 in Detecting Oxygen Level and Blood Vessels in Tumor Cells of Patients Undergoing Photodynamic Therapy for Intraperitoneal or Pleural Cancer

  • Conditions: Malignant Mesothelioma, Metastatic Cancer, Primary Peritoneal Cavity Cancer
  • Status: Completed
  • Last Updated: April 23, 2011

Immunotoxin Therapy in Treating Patients With Advanced Solid Tumors

  • Conditions: Cervical Cancer, Fallopian Tube Cancer, Head and Neck Cancer, Lung Cancer, Malignant Mesothelioma, Ovarian Cancer, Pancreatic Cancer, Primary Peritoneal Cavity Cancer
  • Status: Completed
  • Last Updated: April 23, 2011

Combination Chemotherapy and Tamoxifen in Treating Patients With Solid Tumors

  • Conditions: Adrenocortical Carcinoma, Brain and Central Nervous System Tumors, Head and Neck Cancer, Liver Cancer, Malignant Mesothelioma, Pheochromocytoma, Sarcoma
  • Status: Completed
  • Last Updated: February 6, 2009

Inhaled Doxorubicin in Treating Patients With Advanced Solid Tumors Affecting the Lungs

  • Conditions: Lung Cancer, Malignant Mesothelioma, Metastatic Cancer
  • Status: Completed
  • Last Updated: March 14, 2012

Immunotoxin Therapy in Treating Patients With Advanced Cancer

  • Conditions: Cervical Cancer, Fallopian Tube Cancer, Head and Neck Cancer, Lung Cancer, Malignant Mesothelioma, Ovarian Cancer, Pancreatic Cancer, Primary Peritoneal Cavity Cancer
  • Status: Completed
  • Last Updated: April 23, 2011

Cyclophosphamide Plus Vaccine Therapy in Treating Patients With Advanced Cancer

  • Conditions: Breast Cancer, Colorectal Cancer, Kidney Cancer, Lung Cancer, Malignant Mesothelioma, Pancreatic Cancer
  • Status: Completed
  • Last Updated: June 11, 2009

Sorafenib, Pemetrexed, and Cisplatin in Treating Patients With Advanced Solid Tumors

  • Conditions: Breast Cancer, Colorectal Cancer, Head and Neck Cancer, Lung Cancer, Mesothelioma, Pancreatic Cancer, Prostate Cancer, Sarcoma
  • Status: Completed
  • Last Updated: November 30, 2010

B-Receptor Signaling in Cardiomyopathy

  • Conditions: Carcinomas, Amyloidosis, Anal Cancer, Anemia, Cholangiocarcinoma of the Extrahepatic Bile Duct, Transitional Cell Carcinoma of Bladder, Bone Marrow Transplant Failure, Bone Cancer, Cancer of Brain and Nervous System, Breast Cancer, Carcinoma of the Large Intestine, Endocrine Cancer, Esophageal Cancer, Eye Cancer, Gall Bladder Cancer, Gastric (Stomach) Cancer, Gastrooesophageal Cancer, Gastrointestinal Stromal Tumor (GIST), Gynecologic Cancers, Head and Neck Cancers, Hepatobiliary Neoplasm, Kidney (Renal Cell) Cancer, Leukemia, Lung Cancer, Hodgkin Disease, Lymphoma, Non-Hodgkin, Mesothelioma, Multiple Myeloma, Myelodysplastic Syndromes (MDS), Neuroendocrine Tumors, Myeloproliferative Disorders, Pancreatic Cancer, Prostate Cancer, Skin Cancer, Soft Tissue Sarcoma, Testicular Cancer, Thymus Cancer, Thyroid Cancer
  • Status: Completed
  • Last Updated: October 31, 2011

Safety and Immune Response to a Multi-component Immune Based Therapy (MKC1106-PP) for Patients With Advanced Cancer.

  • Conditions: Ovarian, Melanoma, Renal, Prostate, Colorectal, Endometrial Carcinoma, Cervical Carcinoma, Testicular Cancer, Thyroid Cancer, Small Cell Lung Carcinoma, Mesothelioma, Breast Carcinoma, Esophageal Carcinoma, Gastric Cancer, Pancreatic Carcinoma, Neuroendocrine Cancer, Liver Cancer, Gallbladder Cancer, Biliary Tract Cancer, Anal Carcinoma, Bone Sarcomas, Soft Tissue Sarcomas, Carcinoma of Unknown Origin, Primary
  • Status: Completed
  • Last Updated: August 2, 2010

Interleukin-12 in Treating Patients With Cancer in the Abdomen

  • Conditions: Anal Cancer, Colorectal Cancer, Gallbladder Cancer, Gastric Cancer, Pancreatic Cancer
  • Status: Completed
  • Last Updated: August 4, 2010

Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain

  • Conditions: Cancer
  • Status: Completed
  • Last Updated: February 19, 2012

PV701 in Treating Patients With Advanced or Recurrent Peritoneal Cancer

  • Conditions: Cancer
  • Status: Completed
  • Last Updated: April 23, 2011

MS-275 in Treating Patients With Advanced Solid Tumors or Lymphoma

  • Conditions: Cancer
  • Status: Completed
  • Last Updated: March 14, 2012

Erlotinib in Treating Patients With Solid Tumors and Liver or Kidney Dysfunction

  • Conditions: Cancer
  • Status: Completed
  • Last Updated: September 10, 2009

Rigid Thoracoscopy Versus CT-Guided Pleural Needle Biopsy

  • Conditions: Pleural Effusion, Pleural Diseases
  • Status: Completed
  • Last Updated: July 22, 2008

Phase I Study of OSI-930 and Erlotinib in Cancer Tumors

  • Conditions: Advanced Solid Tumors
  • Status: Completed
  • Last Updated: September 26, 2011

Phase II Study of Imatinib Mesylate in Patients With Life Threatening Malignant Rare Diseases

  • Conditions: Life Threatening Diseases
  • Status: Completed
  • Last Updated: April 18, 2012

Study of Pemetrexed and Bevacizumab in Patients With Head and Neck Cancer

  • Conditions: Cancer
  • Status: Completed
  • Last Updated: April 28, 2011

Continuous Hyperthermic Peritoneal Perfusion (CHPP) With Cisplatin for Children With Peritoneal Cancer

  • Conditions: Peritoneal Neoplasms, Retroperitoneal Neoplasms, Gastrointestinal Neoplasms, Adenocarcinoma, Neuroblastoma, Ovarian Neoplasms, Sarcoma, Adrenocortical Carcinoma, Wilms Tumor, Rhabdomyosarcoma, Desmoplastic Small Round Cell Tumor
  • Status: Completed
  • Last Updated: March 29, 2012
mesothelioma-packet
Name:
Address:
City, State, Zip:
Country:
Phone Number:
Email:
Diagnosis:
Comments:
terms of use